Search details
1.
Association of PSMA PET-derived Parameters and Outcomes of Patients Treated for Oligorecurrent Prostate Cancer.
Radiology
; 309(3): e231407, 2023 Dec.
Article
in English
| MEDLINE | ID: mdl-38051188
2.
Radiation Oncologist Consultations Prior to Radical Prostatectomy: Disparities and Opportunities.
J Urol
; 207(1): 118-126, 2022 01.
Article
in English
| MEDLINE | ID: mdl-34445893
3.
Enhancing International Cancer Organization Collaborations: King Hussein Cancer Center and Princess Margaret Cancer Centre Model for Collaboration.
J Cancer Educ
; 37(3): 763-769, 2022 06.
Article
in English
| MEDLINE | ID: mdl-32926325
4.
Can post-treatment free PSA ratio be used to predict adverse outcomes in recurrent prostate cancer?
BJU Int
; 127(6): 654-664, 2021 06.
Article
in English
| MEDLINE | ID: mdl-32926761
5.
International Multicenter Validation of an Intermediate Risk Subclassification of Prostate Cancer Managed with Radical Treatment without Hormone Therapy.
J Urol
; 201(2): 284-291, 2019 02.
Article
in English
| MEDLINE | ID: mdl-30153435
6.
PMH 9907: Long-term outcomes of a randomized phase 3 study of short-term bicalutamide hormone therapy and dose-escalated external-beam radiation therapy for localized prostate cancer.
Cancer
; 122(16): 2595-603, 2016 Aug 15.
Article
in English
| MEDLINE | ID: mdl-27219522
7.
Dose-response of localized renal cell carcinoma after stereotactic body radiation therapy: A meta-analysis.
Radiother Oncol
; 194: 110216, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38462092
8.
Randomized Trial of Concomitant Hypofractionated Intensity Modulated Radiation Therapy Boost Versus Conventionally Fractionated Intensity Modulated Radiation Therapy Boost for Localized High-Risk Prostate Cancer (pHART2-RCT).
Int J Radiat Oncol Biol Phys
; 119(1): 100-109, 2024 May 01.
Article
in English
| MEDLINE | ID: mdl-37979707
9.
Prospective evaluation of patient-reported anxiety and experiences with adaptive radiation therapy on an MR-linac.
Tech Innov Patient Support Radiat Oncol
; 29: 100240, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-38445180
10.
TOward a comPrehensive supportive Care intervention for Older men with metastatic Prostate cancer (TOPCOP3): A pilot randomized controlled trial and process evaluation.
J Geriatr Oncol
; : 101750, 2024 Mar 22.
Article
in English
| MEDLINE | ID: mdl-38521641
11.
Late Toxicities of Prostate Radiotherapy: Can We Further SMARTen Up the Therapeutic Index?
Eur Urol Focus
; 9(3): 414-418, 2023 05.
Article
in English
| MEDLINE | ID: mdl-37032280
12.
Oligometastasis in Prostate Cancer: Can We Learn from Those "Excluded" from a Phase 2 Trial?
Eur Urol Open Sci
; 52: 79-84, 2023 Jun.
Article
in English
| MEDLINE | ID: mdl-37284049
13.
Long-term oncologic outcomes of low dose-rate brachytherapy compared to hypofractionated external beam radiotherapy for intermediate -risk prostate cancer.
Brachytherapy
; 22(2): 188-194, 2023.
Article
in English
| MEDLINE | ID: mdl-36549968
14.
Practice-based training strategy for therapist-driven prostate MR-Linac adaptive radiotherapy.
Tech Innov Patient Support Radiat Oncol
; 27: 100212, 2023 Sep.
Article
in English
| MEDLINE | ID: mdl-37265510
15.
Prognostic Factor Risk Groups for Clinical Stage I Seminoma: An Individual Patient Data Analysis by the European Association of Urology Testicular Cancer Guidelines Panel and Guidelines Office.
Eur Urol Oncol
; 2023 Nov 09.
Article
in English
| MEDLINE | ID: mdl-37951820
16.
Metastatic progression following multimodal therapy for unfavorable-risk prostate cancer.
Can Urol Assoc J
; 16(4): E220-E226, 2022 Apr.
Article
in English
| MEDLINE | ID: mdl-34812728
17.
Safety of Minimizing Intensity of Follow-up on Active Surveillance for Clinical Stage I Testicular Germ Cell Tumors.
Eur Urol Open Sci
; 40: 46-53, 2022 Jun.
Article
in English
| MEDLINE | ID: mdl-35638085
18.
Refining the definition of biochemical failure in the era of stereotactic body radiation therapy for prostate cancer: The Phoenix definition and beyond.
Radiother Oncol
; 166: 1-7, 2022 01.
Article
in English
| MEDLINE | ID: mdl-34774650
19.
Extended Results and Independent Validation of a Phase 2 Trial of Metastasis-Directed Therapy for Molecularly Defined Oligometastatic Prostate Cancer.
Int J Radiat Oncol Biol Phys
; 114(4): 693-704, 2022 11 15.
Article
in English
| MEDLINE | ID: mdl-36031465
20.
Moving Unfavorable Small-Bowel Anatomy Away From the Prostate to Optimize Radiation Therapy Plans With the GU-Lok.
Pract Radiat Oncol
; 11(6): 510-514, 2021.
Article
in English
| MEDLINE | ID: mdl-34237473